Ligand Pharmaceuticals Acquires Metabasis

Ligand Pharmaceuticals, a biotechnology company, has completed the acquisition of Metabasis Therapeutics, a biopharmaceutical company engaged in developing drugs for diabetes and hyperlipidemia.
TradingMarkets